<i>In-Vitro</i> Assessment of Magnetic Dextran-Spermine Nanoparticles for Capecitabine Delivery to Cancerous Cells
(ندگان)پدیدآور
Ghadiri, MaryamVasheghani-Farahani, EbrahimAtyabi, FatemehKobarfard, FarzadHosseinkhani, Hosseinنوع مدرک
TextResearch article
زبان مدرک
Englishچکیده
Cationic polymeric nanoparticles have great potential for developing drug delivery systemswith limited side effects for tumor medication. The goal of this research is investigation ofcationic dextran-spermine polymer (DS) efficacy for improvement of hydrophilic drug deliveryto negatively charged cancerous cells. Capecitabine (as a hydrophilic antineoplastic drug) wasloaded into the magnetic dextran-spermine nanoparticles (DS-NPs) via ionic gelation. Designof experiments was applied to specify how the significant factors affect size, surface charge andcapecitabine entrapment efficiency of the DS-NPs. Physicochemical properties, in-vitro releaseprofile and cellular studies of the optimized DS-NPs were evaluated. The experimental resultsindicated that DS-NPs with favorable properties can be achieved at an optimized condition of2 mg/mL DS and 0.75 mg/mL tri-polyphosphate (TPP) concentrations, TPP addition rate of 35mL/min, pH 3 of DS solution and super paramagnetic iron oxide nanoparticles (SPION)/DSmass ratio of 0.5. The entrapment efficiency of capecitabine was 26.1% at optimum conditionand drug release at neutral pH after 24 h and acidic pH within 3 h was 56 and 98%, respectively.The cytotoxicity assessment exhibited that capecitabine loaded DS-NPs was more toxic thancorresponding free drug as control. Significant cellular uptake of capecitabine loaded DS-NPsby U87MG glioblastoma cells were proved by Prussian blue staining and TEM, qualitatively.DS-NPs are suitable candidates for delivery of the hydrophilic drugs in cancer treatment anddue to positive charge of the dextran-spermine, the uptake of the hydrophilic drugs by thecancerous cells was improved.
کلید واژگان
CancerControlled release
Drug delivery systems
Factorial design
U87MG
Pharmacutics
شماره نشریه
4تاریخ نشر
2017-11-011396-08-10
ناشر
School of Pharmacy, Shahid Beheshti University of Medical Sciencesسازمان پدید آورنده
Biomedical Engineering Division, Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, Iran.Biomedical Engineering Division, Faculty of Chemical Engineering, Tarbiat Modares University, Tehran, Iran.
Nanotechnology Research Centre, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Innovation Center for Advanced Technology, Matrix, Inc., New York 10029, USA.
شاپا
1735-03281726-6890




